Average Co-Inventor Count = 5.55
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Sciences Ireland Uc (11 from 111 patents)
2. Janssen R&d Ireland (2 from 45 patents)
3. Tibotec Pharmaceuticals Ltd. (1 from 66 patents)
4. Janssen Sciences Ireland Unlimited Company (1 from 60 patents)
15 patents:
1. 11096931 - Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
2. 11078193 - Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
3. 10875876 - Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
4. 10457638 - Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
5. 10398677 - N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
6. 10377709 - Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
7. 10160743 - Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
8. 10071961 - Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
9. 9895349 - N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
10. 9884818 - Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
11. 9567299 - Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
12. 9233933 - 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis B
13. 8664391 - Amide compounds as boosters of antivirals
14. 8350048 - Amide compounds as boosters of antivirals
15. 7615639 - 1-pyridyl-benzofuro[3,2-b]pyridin-2(1H)-ones